On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School of Medicine has been designated a qualified provider-led entity (qPLE). This allows Johns Hopkins to develop criteria that meet the requirements of the federal Protecting Access to Medicare Act (PAMA) of 2014 when ordering diagnostic imaging tests such as computed tomography (CT) scans, magnetic resonance imaging (MRI) scans and nuclear imaging in the emergency department and ambulatory settings.

The Centers for Medicare and Medicaid Services (CMS) issued a proposal for an advanced alternative payment model (APM) for radiation oncology on July 10, 2019. In response, the American Society for Radiation Oncology (ASTRO) issued the following statement from Paul Harari, M.D., FASTRO, chair of the ASTRO Board of Directors.

The International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (GLCC) and AstraZeneca announced the Lung Ambition Alliance, a new partnership with a bold ambition to eliminate lung cancer as a cause of death. The first goal of the alliance will be to double five-year survival for patients with lung cancer by 2025.